BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Pascoal LB, Bombassaro B, Ramalho AF, Coope A, Moura RF, Correa-da-Silva F, Ignacio-Souza L, Razolli D, de Oliveira D, Catharino R, Velloso LA. Resolvin RvD2 reduces hypothalamic inflammation and rescues mice from diet-induced obesity. J Neuroinflammation 2017;14:5. [PMID: 28086928 DOI: 10.1186/s12974-016-0777-2] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 4.4] [Reference Citation Analysis]
Number Citing Articles
1 Parolini C. Marine n-3 polyunsaturated fatty acids: Efficacy on inflammatory-based disorders. Life Sci 2020;263:118591. [PMID: 33069735 DOI: 10.1016/j.lfs.2020.118591] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
2 Morari J, Haddad-tóvolli R, Silva Nogueira PA, Teixeira CJ, Maróstica R, Tobar N, Ramos CD, Velloso LA, Dias Bobbo VC, Anhê GF. Body mass variability in age-matched outbred male Swiss mice is associated to differential control of food intake by ghrelin. Molecular and Cellular Endocrinology 2022. [DOI: 10.1016/j.mce.2022.111646] [Reference Citation Analysis]
3 Han YH, Lee K, Saha A, Han J, Choi H, Noh M, Lee YH, Lee MO. Specialized Proresolving Mediators for Therapeutic Interventions Targeting Metabolic and Inflammatory Disorders. Biomol Ther (Seoul) 2021;29:455-64. [PMID: 34162770 DOI: 10.4062/biomolther.2021.094] [Reference Citation Analysis]
4 Duan J, Song Y, Zhang X, Wang C. Effect of ω-3 Polyunsaturated Fatty Acids-Derived Bioactive Lipids on Metabolic Disorders. Front Physiol 2021;12:646491. [PMID: 34113260 DOI: 10.3389/fphys.2021.646491] [Reference Citation Analysis]
5 Zuo G, Zhang D, Mu R, Shen H, Li X, Wang Z, Li H, Chen G. Resolvin D2 protects against cerebral ischemia/reperfusion injury in rats. Mol Brain 2018;11:9. [PMID: 29439730 DOI: 10.1186/s13041-018-0351-1] [Cited by in Crossref: 35] [Cited by in F6Publishing: 32] [Article Influence: 8.8] [Reference Citation Analysis]
6 Miao Z, Tang X, Schultzberg M, Zhao Y, Wang X. Plasma Resolvin D2 to Leukotriene B4 Ratio Is Reduced in Diabetic Patients with Ischemic Stroke and Related to Prognosis. Biomed Res Int 2021;2021:6657646. [PMID: 33728336 DOI: 10.1155/2021/6657646] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
7 Félix-Soriano E, Sáinz N, Gil-Iturbe E, Collantes M, Fernández-Galilea M, Castilla-Madrigal R, Ly L, Dalli J, Moreno-Aliaga MJ. Changes in brown adipose tissue lipid mediator signatures with aging, obesity, and DHA supplementation in female mice. FASEB J 2021;35:e21592. [PMID: 33960028 DOI: 10.1096/fj.202002531R] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
8 Ulu A, Sahoo PK, Yuil-Valdes AG, Mukherjee M, Van Ormer M, Muthuraj PG, Thompson M, Anderson Berry A, Hanson CK, Natarajan SK, Nordgren TM. Omega-3 Fatty Acid-Derived Resolvin D2 Regulates Human Placental Vascular Smooth Muscle and Extravillous Trophoblast Activities. Int J Mol Sci 2019;20:E4402. [PMID: 31500240 DOI: 10.3390/ijms20184402] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
9 Lacombe RJS, Chouinard-Watkins R, Bazinet RP. Brain docosahexaenoic acid uptake and metabolism. Mol Aspects Med 2018;64:109-34. [PMID: 29305120 DOI: 10.1016/j.mam.2017.12.004] [Cited by in Crossref: 54] [Cited by in F6Publishing: 48] [Article Influence: 13.5] [Reference Citation Analysis]
10 Lian J, Casari I, Falasca M. Modulatory role of the endocannabinoidome in the pathophysiology of the gastrointestinal tract. Pharmacol Res 2021;175:106025. [PMID: 34883211 DOI: 10.1016/j.phrs.2021.106025] [Reference Citation Analysis]
11 Gc JB, Szlenk CT, Gao J, Dong X, Wang Z, Natesan S. Molecular Dynamics Simulations Provide Insight into the Loading Efficiency of Proresolving Lipid Mediators Resolvin D1 and D2 in Cell Membrane-Derived Nanovesicles. Mol Pharm 2020;17:2155-64. [PMID: 32374613 DOI: 10.1021/acs.molpharmaceut.0c00299] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
12 Fourrier C, Capuron L, Castanon N. Role of Inflammation in Neuropsychiatric Comorbidity of Obesity: Experimental and Clinical Evidence. Inflammation and Immunity in Depression. Elsevier; 2018. pp. 357-75. [DOI: 10.1016/b978-0-12-811073-7.00020-9] [Cited by in Crossref: 2] [Article Influence: 0.5] [Reference Citation Analysis]
13 Shang P, Zhang Y, Ma D, Hao Y, Wang X, Xin M, Zhang Y, Zhu M, Feng J. Inflammation resolution and specialized pro-resolving lipid mediators in CNS diseases. Expert Opin Ther Targets 2019;23:967-86. [PMID: 31711309 DOI: 10.1080/14728222.2019.1691525] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
14 Fabisiak A, Fabisiak N, Mokrowiecka A, Malecka-Panas E, Jacenik D, Kordek R, Zielińska M, Kieć-Kononowicz K, Fichna J. Novel selective agonist of GPR18, PSB-KK-1415 exerts potent anti-inflammatory and anti-nociceptive activities in animal models of intestinal inflammation and inflammatory pain. Neurogastroenterol Motil 2021;33:e14003. [PMID: 33058313 DOI: 10.1111/nmo.14003] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
15 Morales P, Lago-Fernandez A, Hurst DP, Sotudeh N, Brailoiu E, Reggio PH, Abood ME, Jagerovic N. Therapeutic Exploitation of GPR18: Beyond the Cannabinoids? J Med Chem 2020;63:14216-27. [PMID: 32914978 DOI: 10.1021/acs.jmedchem.0c00926] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
16 Vander Ploeg M, Quinn K, Armstrong M, Manke J, Reisdorph N, Shaikh SR. SPM pathway marker analysis of the brains of obese mice in the absence and presence of eicosapentaenoic acid ethyl esters. Prostaglandins Leukot Essent Fatty Acids 2021;175:102360. [PMID: 34743051 DOI: 10.1016/j.plefa.2021.102360] [Reference Citation Analysis]
17 Chiang N, Serhan CN. Structural elucidation and physiologic functions of specialized pro-resolving mediators and their receptors. Mol Aspects Med 2017;58:114-29. [PMID: 28336292 DOI: 10.1016/j.mam.2017.03.005] [Cited by in Crossref: 138] [Cited by in F6Publishing: 134] [Article Influence: 27.6] [Reference Citation Analysis]
18 Deyama S, Ishikawa Y, Yoshikawa K, Shimoda K, Ide S, Satoh M, Minami M. Resolvin D1 and D2 Reverse Lipopolysaccharide-Induced Depression-Like Behaviors Through the mTORC1 Signaling Pathway. Int J Neuropsychopharmacol 2017;20:575-84. [PMID: 28419244 DOI: 10.1093/ijnp/pyx023] [Cited by in Crossref: 43] [Cited by in F6Publishing: 43] [Article Influence: 10.8] [Reference Citation Analysis]
19 Pascoal LB, Palma BB, Chaim FHM, de Castro MM, Damázio TA, Franceschini APMF, Milanski M, Velloso LA, Leal RF. New translational and experimental insights into the role of pro-resolving lipid mediators in inflammatory bowel disease. World J Exp Med 2022; 12(1): 1-15 [DOI: 10.5493/wjem.v12.i1.1] [Reference Citation Analysis]
20 Pal A, Gowdy KM, Oestreich KJ, Beck M, Shaikh SR. Obesity-Driven Deficiencies of Specialized Pro-resolving Mediators May Drive Adverse Outcomes During SARS-CoV-2 Infection. Front Immunol 2020;11:1997. [PMID: 32983141 DOI: 10.3389/fimmu.2020.01997] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
21 de Carvalho Marchesin J, Celiberto LS, Orlando AB, de Medeiros AI, Pinto RA, Zuanon JAS, Spolidorio LC, dos Santos A, Taranto MP, Cavallini DCU. A soy-based probiotic drink modulates the microbiota and reduces body weight gain in diet-induced obese mice. Journal of Functional Foods 2018;48:302-13. [DOI: 10.1016/j.jff.2018.07.010] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
22 Zhang L, Liu Z, Zhu Q, Wen S, Yang C, Fu Z, Sun T. Resolvin D2 Relieving Radicular Pain is Associated with Regulation of Inflammatory Mediators, Akt/GSK-3β Signal Pathway and GPR18. Neurochem Res 2018;43:2384-92. [DOI: 10.1007/s11064-018-2666-9] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
23 Angelidi AM, Belanger MJ, Kokkinos A, Koliaki CC, Mantzoros CS. Novel Non-invasive Approaches to the Treatment of Obesity: From Pharmacotherapy to Gene Therapy. Endocr Rev 2021:bnab034. [PMID: 34698815 DOI: 10.1210/endrev/bnab034] [Reference Citation Analysis]
24 Dragano NR, Monfort-pires M, Velloso LA. Mechanisms Mediating the Actions of Fatty Acids in the Hypothalamus. Neuroscience 2020;447:15-27. [DOI: 10.1016/j.neuroscience.2019.10.012] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
25 Ramírez-Orozco RE, García-Ruiz R, Morales P, Villalón CM, Villafán-Bernal JR, Marichal-Cancino BA. Potential metabolic and behavioural roles of the putative endocannabinoid receptors GPR18, GPR55 and GPR119 in feeding. Curr Neuropharmacol 2019;17:947-60. [PMID: 31146657 DOI: 10.2174/1570159X17666190118143014] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]